Table 4

Definitions of resistance after discontinuing treatment for metastatic disease

Stopped therapy (CR/PR/end of study/other social rationale)Duration of time after last dose of PD-(L)1 inhibitorConfirmatory scan requirement
Primary resistanceNo CR/PR prior to discontinuationNo
Secondary resistancePrior CR/PR and ≤12 weeks from last doseYes
Late progressionPrior CR/PR and >12 weeks from last doseYes
  • CR, complete response; PD, programmed death; PR, partial response.